Platelets are the critical target for preventing and treating pathological thrombus formation. However, despite current antiplatelet therapy, cardiovascular mortality remains high, and cardiovascular events continue in prescribed patients. In this study, first results were obtained with ortho-carbonyl hydroquinones as antiplatelet agents; we found that linking triphenylphosphonium cation to a bicyclic ortho-carbonyl hydroquinone moiety by a short alkyl chain significantly improved their antiplatelet effect by affecting the mitochondrial functioning. The mechanism of action involves uncoupling OXPHOS, which leads to an increase in mitochondrial ROS production and a decrease in the mitochondrial membrane potential and OCR. This alteration disrupts the energy production by mitochondrial function necessary for the platelet activation process. These effects are responsive to the complete structure of the compounds and not to isolated parts of the compounds tested. The results obtained in this research can be used as the basis for developing new antiplatelet agents that target mitochondria.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002875PMC
http://dx.doi.org/10.1016/j.redox.2024.103142DOI Listing

Publication Analysis

Top Keywords

linking triphenylphosphonium
8
triphenylphosphonium cation
8
cation bicyclic
8
mitochondrial function
8
antiplatelet agents
8
antiplatelet
5
mitochondrial
5
bicyclic hydroquinone
4
hydroquinone improves
4
improves antiplatelet
4

Similar Publications

MITOCDNB DECREASES PLATELET ACTIVATION THROUGH ITS SELECTIVE ACTION ON MITOCHONDRIAL THIOREDOXIN REDUCTASE.

Biomed Pharmacother

January 2025

Thrombosis and Healthy Aging Research Center, MIBI: Interdisciplinary Group on Mitochondrial Targeting and Bioenergetics, Medical Technology School, Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, Universidad de Talca, Talca, Chile. Electronic address:

Platelet inhibition is a fundamental objective to prevent and treat thrombus formation. Platelet activation depends on mitochondrial function. This study aims to identify a new mitochondria-targeting compound with antiplatelet activity at safe concentrations in vitro.

View Article and Find Full Text PDF

A mitochondrion-targeted poly(N-isopropylacrylamide-coacrylic acid) nanohydrogel with a fluorescent bioprobe for ferrous ion imaging in vitro and in vivo.

Spectrochim Acta A Mol Biomol Spectrosc

January 2025

School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang 310007, China; Department of Medicine, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang 310007, China. Electronic address:

An imbalance in iron homeostasis contributes to mitochondrial dysfunction, which is closely linked to the pathogenesis of various diseases. Herein, we developed a nanosensor for detecting mitochondrial ferrous ions in vitro and in vivo. A poly(N-isopropylacrylamine)-coacrylic acid nanohydrogel was synthesized, and ferrous ions were detected using the fluorescent probe FeRhonox-1 embedded within it.

View Article and Find Full Text PDF

First Report on Cationic Triphenylphosphonium Compounds as Mitochondriotropic HR Ligands with Antioxidant Properties.

Antioxidants (Basel)

November 2024

Departamento de Farmacia, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.

Article Synopsis
  • - Neurodegenerative diseases are increasingly prevalent, prompting research for new treatments; a series of six novel compounds were synthesized to target mitochondrial oxidative stress and show potential as therapeutic agents.
  • - These compounds displayed varying affinities for their target, with one compound achieving notable affinity comparable to an existing drug, and demonstrated antioxidant properties, although their effectiveness was only low to moderate.
  • - The research included evaluation of these compounds' effects on neuroblastoma cells, revealing a clear link between chemical structure and toxicity, alongside computational studies aimed at refining their design for better therapeutic utility.
View Article and Find Full Text PDF

Hepatocytes and mitochondria dual-targeted astaxanthin WPI-SCP nanoparticles for the alleviation of alcoholic liver injury.

Int J Biol Macromol

January 2025

State Key Laboratory of Marine Food Processing and Safety Control, Dalian Polytechnic University, Dalian 116034, Liaoning, China; Academy of Food Interdisciplinary Science, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, Liaoning, China; National Engineering Research Center of Seafood, Dalian Polytechnic University, Dalian 116034, Liaoning, China; Dalian Key Laboratory for Precision Nutrition, Dalian Polytechnic University, Dalian 116034, Liaoning, China; Dalian Jinshiwan Laboratory, Dalian 116034, Liaoning, China. Electronic address:

Alcoholic liver injury is one of the most frequent liver diseases around the world, and nutritional intervention has been considered as an effective way to alleviate alcohol liver injury. To alleviate the liver damage caused by alcohol, a type of astaxanthin (AXT) loaded nanoparticles were designed for dual targeting of hepatocytes and mitochondria. Firstly, galactooligosaccharides (GOS) were conjugated to whey protein isolate (WPI) and sea cucumber peptide (SCP) via the Maillard reaction, achieving a grafting degree of 29 %, then triphenylphosphonium (TPP) was linked by amide reaction.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer is a major cause of death, and recent research is focusing on quinazolinone compounds for their potential anticancer properties.
  • The study involved designing and synthesizing 24 new derivatives with TPP linked to quinazolinone, testing their effectiveness against various cancer cell lines.
  • Some new compounds showed significant anticancer effects, outperforming the positive control drug gefitinib, indicating potential for further research on their use in cancer treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!